Table: begin end state 1 27 cytoplasmic 28 51 transmembrane 52 56 non-cytoplasmic 57 79 transmembrane 80 99 cytoplasmic 100 124 transmembrane 125 159 non-cytoplasmic 160 179 transmembrane 180 186 cytoplasmic 187 211 transmembrane 212 230 non-cytoplasmic 231 254 transmembrane 255 265 cytoplasmic 266 288 transmembrane 289 313 non-cytoplasmic 314 338 transmembrane 339 369 cytoplasmic 370 388 transmembrane 389 393 non-cytoplasmic 394 412 transmembrane 413 423 cytoplasmic 424 444 transmembrane 445 449 non-cytoplasmic 450 467 transmembrane 468 483 cytoplasmic
Input: >CA265_RS17395 MKKSIASIVAEANESGEGSLKRTLGPINLILIGVGLTLGAGLFSITGLAAANHSGPAVTL SFVIAALGCGFAALCYAEFASMIPVAGSAYTYSYATMGELFAWIIGWDLVLEYSVGCATV AISWSQYLTKFLASLHIYLPPQLTLSPFETAKLADGSTVNGIINIPAALVVVLMTAILIR GTKGSAIVNGIIVFLKVGVVLVFIALGWQYIDPANYHPYIPENTGTFGQFGWSGVLRGAG LVFFVFIGFDAVAASAQETKNPARDLPIGIIGSLLVCTVLFGLFGHVMTGLANYKEFANS GAPVAIAIEKTPYAWLSQAIILAILIGYTSVILIDLMAQSRMFYSISKDGLLPKMFSDVH AKFKTPYKSNIILCVFIGLFAAFVPMNVVGEMTSIGTLLAFLMVCVGILILRKTNPEAKR PFKVPFVPLIPILGILTCIAMMVFLPWETWLRLAVWLIIGLAIYFWYGKKNSKLKAQEEQ TKL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server